KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Elevance Health (ELV) Divestments (2014 - 2024)

Elevance Health (ELV) reported Divestments of -$36.0 million for Q4 2024, up 99.23% on a QoQ basis from -$4.7 billion in Q4 2016.

Elevance Health (ELV) has 3 years of Divestments data on file, last reported at -$36.0 million in Q4 2024.

Quarterly Divestments changed N/A year-over-year to -$36.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$36.0 million (changed 0.0% YoY) and the FY2024 annual result came in at $363.0 million, changed N/A from the prior year.
Divestments advanced to -$36.0 million in Q4 2024 per ELV's latest filing, from -$4.7 billion in the prior quarter.
Across five years, Divestments topped out at -$36.0 million in Q4 2024 and bottomed at -$36.0 million in Q4 2024.

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2024	-36.00 Mn
Dec 31, 2016	-4.68 Bn
Mar 31, 2016	4.68 Bn
Mar 31, 2014	740.00 Mn